• In late April 2026, Keurig Dr Pepper reported that first-quarter net sales rose to US$3.98 billion from US$3.64 billion a year earlier, while net income fell to US$270 million from US$517 million, and reaffirmed full-year 2026 guidance for net sales of US$25.90 billion to US$26.40 billion along with high single-digit second-quarter EPS growth.
• A key development was the renewed and expanded partnership with Nestlé USA to manufacture and distribute Starbucks K‑Cup pods in the U.S. and Canada, which aligns with Keurig Dr Pepper’s broader coffee ambitions following its completion of the JDE Peet’s acquisition.
• We’ll now explore how reaffirmed 2026 guidance, alongside the expanded Starbucks K‑Cup partnership, reshapes Keurig Dr Pepper’s investment narrative.

The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 18 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.

Keurig Dr Pepper Investment Narrative Recap

To own Keurig Dr Pepper, you need to believe in its ability to balance a resilient cold-beverage engine with a turnaround in coffee, while integrating JDE Peet’s and preparing for a future split into separate beverage and coffee companies. The reaffirmed 2026 sales and EPS outlook, despite weaker first quarter net income, supports the near term catalyst of execution on growth and integration, while persistent coffee margin pressure and input costs remain the key risk.

The renewed and expanded Nestlé partnership around Starbucks K Cup pods directly ties into KDP’s coffee ambitions and the JDE Peet’s acquisition, reinforcing the coffee platform catalyst even as the U.S. Coffee segment has recently been under pressure.

Yet investors should be aware that rising tariffs on green coffee and brewers could still pressure profitability if...

Keurig Dr Pepper's narrative projects $31.2 billion revenue and $3.7 billion earnings by 2029. This requires 22.6% yearly revenue growth and roughly a $1.9 billion earnings increase from $1.8 billion today.

Uncover how Keurig Dr Pepper's forecasts yield a $33.25 fair value, a 14% upside to its current price.

Exploring Other Perspectives

Nine fair value estimates from the Simply Wall St Community span roughly US$20.60 to US$61.01 per share, showing how far apart individual views can be. Against this wide range, the reaffirmed 2026 guidance and expanded Starbucks K Cup partnership highlight why different investors may focus either on growth catalysts or the unresolved risks in U.S. Coffee margins.

Explore 9 other fair value estimates on Keurig Dr Pepper - why the stock might be worth over 2x more than the current price!

Decide For Yourself

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your Keurig Dr Pepper research is our analysis highlighting 3 key rewards and 1 important warning sign that could impact your investment decision.
• Our free Keurig Dr Pepper research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Keurig Dr Pepper's overall financial health at a glance.

Ready To Venture Into Other Investment Styles?

These stocks are moving-our analysis flagged them today. Act fast before the price catches up:

• AI is about to change healthcare. These 33 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
• Uncover the next big thing with 24 elite penny stocks that balance risk and reward.
• The future of work is here. Discover the 33 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.